
Keraplast makes bioactive New Zealand wool keratin ingredients partners formulate into products for personal care, nutraceutical, and wound care markets.
keraplast.comCrawled Oct 15, 2026
Careers Join The Team See positions available at Kerplast and join a team changing the world. Open positions
Keraplast lists its address in Christchurch, New Zealand, and its phone number, +64 3 325 9100.
Keraplast manufactures soluble, bioactive keratin proteins and peptides from regeneratively farmed New Zealand sheep’s wool. The page states that its products are sold in 22 countries and describes four extraction processes.
Keraplast Manufacturing is a wholly owned subsidiary of Keraplast Technologies LLC. Keraplast supplies branded ingredients for personal care and nutraceutical supplement manufacturers and distributors in global markets, including Europe and China.
Behn Meyer Personal Care introduces Keraplast’s wool-derived keratin ingredients to Southeast Asian markets through a new partnership. The collaboration expands access to natural, renewable, and traceable keratin-based formulations for personal care products. Keraplast’s ingredients are sourced from wool, aligning with sustainability goals in the beauty industry.
Oct 2026Behn MeyerNews article
Keraplast secures a five-year wool supply agreement with approximately 30 farmers. The company, based in Christchurch, uses wool in manufacturing wound and other care products. This contract supports its supply chain for raw materials.
Feb 2026odt.co.nzNews article
Wools of New Zealand (WONZ) and Keraplast launch a five-year contract guaranteeing **40% premium pricing above market rates** for strong-wool growers. The agreement secures long-term demand and financial support for farmers producing high-value, regenerative wool. Both companies emphasize sustainable supply chains as a key driver of the partnership.
Feb 2026KeraplastNews article
BioWound Solutions partners with Keraplast to manufacture its keratin-based wound care products—Keramatrix®, Keragel®, and Kerox®—exclusively for the US market. The agreement expands production capacity for BioWound’s advanced wound management solutions. Keraplast, a New Zealand biotechnology firm, will handle manufacturing under the exclusive deal.
Oct 2025KeraplastNews article